Purpose of module, The ICIQ-UI Short Form provides a brief and robust This short and simple questionnaire is also of use to general practitioners and. The Patient Global Impression of Improvement (PGI-I) and International Consultation of Incontinence Questionnaire – Short Form (ICIQ-SF) are. The ICIQ-SF questionnaire is used for evaluation of clinical manifestations in patients with urinary incontinence (UI) alone and combination of UI with lower.
|Published (Last):||19 May 2014|
|PDF File Size:||15.32 Mb|
|ePub File Size:||5.83 Mb|
|Price:||Free* [*Free Regsitration Required]|
The correlations and cut-off scores generated were then validated on two independent datasets representing the 1-year and 4-year follow-up periods of the multicentre RCT in six units in the UK.
Significant correlations at the 0. Our study fills a research gap in providing a way to compare trial results when baseline ICIQ-SF scores are not available. A number of self-assessment questionnaires have been recommended [ 34 ], but simplicity and brevity are important features in designing patient self-assessment questionnaires [ 34 ].
Items 1 and 2 are demographic and the final item is a self-diagnostic item for the type of UI. However, there is a paucity of evidence as to what represents a successful postintervention ICIQ-SF score, and this is auestionnaire complicated when the baseline score is not available [ 5 ].
Such a score would facilitate the comparison of results among clinical trials using different tools to asses PROM and especially those in which long-term follow-up is feasible. Such a score could also be a valuable aid in the counselling of patients and facilitating their postoperative follow-up.
Two PROM assessment tools were assessed: The PGI-I is a seven-point transition scale that comprises a single question asking patients to rate their urinary tract condition now as compared with how it was before treatment on a scale from 1 very much better to 7 very much worse. These datasets were from patients who responded to follow-up postal questionnaire packs which also included symptom severity, QoL and sexual function questionnaires.
We used the usual convention for the PGI-I transition qurstionnaire from 1 very much better questiinnaire 7 very much worse. We determined the xf between absolute scores. We did not stratify the ICIQ-SF ici into mild, moderate and ifiq, as this procedure has been shown to have limited validity [ 9 ].
Correlation analysis was then done yielding Pearson coefficients. These were used to generate sensitivity and specificity cut-off values. Tukey type post-hoc analysis was performed. The PGI-I is a global index that is widely used to rate the response of a condition to a therapy transition scale. It is a simple, direct, easy to use scale that is intuitively understandable by clinicians and patients [ 3 ].
The PGI-I has been found to have quetionnaire construct validity when compared with various assessment variables: Such global ratings can be precise when used to assess the same person over time, but they have a degree of imprecision across the spectrum of different qhestionnaire in whom they might be used [ 5 ].
PGI-I has recently been found by Hossack and Woo to be a valid assessment tool even following prostatectomy, and PGI-I is now being looked at with great interest in urology research. It has shown excellent correlation with the symptom score and QoL index in urology research [ 17 ]. This PROM tool takes 5 min or less time to administer and no training, and hence ociq widely used in both clinical and research settings. Cut-off scores for severity of UI in women have been reported by Klovning et al.
Score ranges were 1 — 5 slight6 — 12 moderate13 — 18 severe and 19 — 21 very severe. The minimal detectable change MDC and minimally clinically important difference MCID after intervention for UI are not yet established, but there has been initial investigation in this area [ 5 — 10 ]. They concluded that MID may be overestimated in surgical cohorts because of uniformly high preoperative scores without significant variability that show a large improvement after treatment [ 10 ]. They included women with a 4-month follow-up.
The MID was defined as the mean change in score in women who experienced a small improvement.
The clear discrepancy between MCID in the above studies shows that more research is needed in this area. This demonstrated that the results are fully validated for the majority of women undergoing treatment with a MUS. This would allow the clinical community to fill the gap in the evidence for the long-term outcomes following surgical treatment of SUI. In-addition, this novel validated ICIQ-SF cut-off score will be a valuable aid in counselling patients during their follow-up after surgery for incontinence.
Recently, Larsen et al. In the accompanying editorial, Cartwright et al. The fact that the cut-off score did not seem to be affected by the length of follow-up or the type of MUS used is important for both clinical and research use. A potential limitation is that correlating two questionnaires that measure the same clinical intervention may be inappropriate.
PGI-I provides a more global overview of treatment success that is more likely to fully encompass the range of benefits and harms of surgery compared to a disease-specific questionnaire such as ICIQ. Our study fills the research gap in providing a way to compare trial results when baseline ICIQ-SF scores are not available.
Mohamed Abdel-fattah certifies that the conflicts of interest, including specific financial interests and relationships and affiliations relevant to the subject matter or materials discussed in the article e. All authors of this paper have received travel grants from different pharmaceutical companies Pfizer, Astellas, Lilly, Ethicon, Coloplast to attend medical conferences.
The University of Aberdeen received a research grant from Coloplast in National Center for Biotechnology InformationU.
ICIQ – UI Short Form |
Published online Jul 5. Author information Article notes Copyright and License information Disclaimer. Received Jan 21; Accepted Jun 6. This article has been cited by other articles in PMC. Results Significant correlations at the 0.
Open in a separate window. Methodology In the accompanying editorial, Cartwright et al. Financial disclosures Mohamed Abdel-fattah certifies that the conflicts of interest, including specific financial interests and relationships and affiliations relevant to the subject matter or materials discussed in the article e. Hilton P, Robinson Questinonaire. Initial assessment of urinary and faecal incontinence in adult male and female patients.
ICIQ | Urinary Incontinence Form
Health Publication Ltd; Symptom and quality of life assessment. Comparison of the ICIQ-SF and hour pad test with other measures for evaluating the severity of urodynamic stress incontinence.
Prospective randomised controlled trial of transobturator tapes in management of urodynamic stress incontinence in women: Int Urogynecol J 26 1 suppl: Multicenter prospective randomized study of single-incision mini-sling vs tension-free vaginal tape-obturator in management of female stress urinary sv Comparison of two questionnaires for assessing the severity of urinary incontinence: The minimum important difference for the International Consultation on Incontinence Questionnaire-Urinary Incontinence Short Form in women with stress urinary incontinence.
ICIQ symptom and quality of life instruments measure clinically relevant improvements in women with stress urinary incontinence. Mid-urethral sling operations for stress urinary incontinence in women.
[ICIQ-SF questionnaire in women with urinary incontinence].
Cochrane Database Syst Rev. Discrepancies between patient-reported outcome measures when assessing ixiq incontinence or pelvic- prolapse surgery. Patient reported outcome measures after incontinence and prolapse surgery: Bladder ultrasonography for diagnosing detrusor overactivity: Hossack T, Woo H.
Validation of a patient reported outcome questionnaire for assessing success of endoscopic prostatectomy. Patient-selected goals in overactive bladder: Support Center Support Center.